1. Home
  2. BRZE vs VCEL Comparison

BRZE vs VCEL Comparison

Compare BRZE & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braze Inc.

BRZE

Braze Inc.

HOLD

Current Price

$26.48

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$46.71

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRZE
VCEL
Founded
2011
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
BRZE
VCEL
Price
$26.48
$46.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
26
5
Target Price
$37.88
$57.75
AVG Volume (30 Days)
2.2M
704.3K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
N/A
Revenue
$738,182,000.00
$276,259,000.00
Revenue This Year
$22.69
$19.40
Revenue Next Year
$16.93
$18.24
P/E Ratio
N/A
N/A
Revenue Growth
24.40
16.45
52 Week Low
$15.26
$28.95
52 Week High
$37.33
$48.75

Technical Indicators

Market Signals
Indicator
BRZE
VCEL
Relative Strength Index (RSI) 68.53 62.42
Support Level $26.02 $32.47
Resistance Level $29.14 N/A
Average True Range (ATR) 1.27 1.81
MACD 0.42 -0.21
Stochastic Oscillator 91.41 60.92

Price Performance

Historical Comparison
BRZE
VCEL

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates the majority of its revenue from the United States.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: